Yuting Liu

Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models

Andreas Weihofen, Yuting Liu, Joseph W. Arndt et al. · Neurobiology of Disease · 2018 · 188 citations · Full text

Disease Models, Neurodegenerative Diseases, α-Syn Pathology +15

Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054

Laura Fanning, Serena Hung, Aaron Ellenbogen et al. · Movement Disorders · 2019 · 187 citations · Full text

The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: a meta-analysis.

Shunzeng Lv, Yuting Liu, Zhigeng Zou et al. · PubMed · 2015 · 75 citations

The Parkinson’s disease-associated gene ITPKB protects against α-synuclein aggregation by regulating ER-to-mitochondria calcium release

Daniel J. Apicco, Evgeny Shlevkov, Catherine L. Nezich et al. · Proceedings of the National Academy of Sciences · 2020 · 61 citations · Full text

Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand

D.J. Marcotte, Yuting Liu, Kevin Little et al. · BMC Structural Biology · 2016 · 31 citations · Full text